This review summarizes recent evidence on how mid‐life hypertension,
hyperhomocysteinemia (HHcy) and blood pressure variability, as well as late‐life …

Traumatic brain injury (TBI) is a major public health problem, with limited pharmacological
options available beyond symptomatic relief. The renin angiotensin system (RAS) is …

Background: Renin-angiotensin system (RAS) inhibitors have been suggested as protective
agents in Parkinson's disease (PD). However, epidemiological evidence on the association …

Background Recent studies on renin-angiotensin system (RAS) inhibitors have reported a
reduced risk of Alzheimer's disease (AD). Nevertheless, the effect of RAS inhibitor type and …

Calcium channel blockers (CCBs) differ in their ability to penetrate into the brain.
Pharmacoepidemiological studies suggest that CCBs as a class may have beneficial effects …

Observational studies suggest that angiotensin receptor blockers in hypertensive adults are
associated with lower post-mortem indicators of Alzheimer's disease pathology …

Abstract Purpose of Review To provide an overview of the association between angiotensin
II receptor blocker (ARB) use and cognitive outcomes. Recent Findings ARBs have …

Hypertension is the most prevalent and modifiable risk factor for stroke, vascular cognitive
impairment, and Alzheimer's disease. However, the mechanistic link between hypertension …

The Renin–Angiotensin System (RAS) has attracted considerable interest beyond its
traditional cardiovascular role due to emerging data indicating its potential involvement in …

Brain neurodegenerative diseases (BND) are debilitating conditions that are especially
characteristic of a certain period of life and considered major threats to human health …